Shandong Longzen Pharmaceutical Co., Ltd.
Shandong Longzen Pharmaceutical Co., Ltd., a subsidiary of Suzhou Medinoah Co., Ltd., was established in December 2020 within the ZouPing National Economic and Technological Development Zone of Shandong Province. Covering 40 acres with a construction area of 95,000 square meters, our total investment exceeds US$100 million.
Longzen is committed to being a modern pharmaceutical company that seamlessly integrates product research and development, manufacturing, sales, and marketing. We offer alpha-lipoic acids and R-(+)-lipoic acid in pharma and premium grades, meeting diverse certifications and standards worldwide.
Our focus on quality is unwavering. We maintain a fully integrated process, adhere strictly to Good Manufacturing Practices (GMP), and ensure an unmatched impurity profile in our products.
With an executive team boasting over 20 years of experience in drug research and development, particularly in alpha-lipoic acid, and supported by a dedicated R&D team, Longzen is well-equipped to meet the needs of our customers with tailored formulations
Brands: LipoZEN